DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 7.85

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-03 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.13% 57% F 60% D-
Dividend Return 0.35% 10% F 6% D-
Total Return 0.22% 48% F 56% F
Trailing 12 Months  
Capital Gain -6.44% 10% F 47% F
Dividend Return 2.98% 41% F 34% F
Total Return -3.45% 9% A- 47% F
Trailing 5 Years  
Capital Gain 24.60% 37% F 58% F
Dividend Return 11.62% 26% F 21% F
Total Return 36.22% 32% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.68% 61% D- 56% F
Dividend Return 7.58% 61% D- 55% F
Total Return 1.89% 54% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 8.30% 64% D 91% A-
Risk Adjusted Return 91.29% 84% B 94% A
Market Capitalization 0.17B 33% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.